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Abstract
Purpose: To evaluate the feasibility of using volumetric modulated arc therapy (VMAT) using RapidArc to deliver total body
irradiation (TBI) treatment. Methods: VMAT planning was performed a whole body computed tomography (CT) data set using
Rapid Arc. The planning target volumes included entire body trimmed to 3 mm below the skin. The organs at risk included the
lungs and kidneys. A dose of 12 Gy in 10 fractions was prescribed to the target volume. The VMAT-TBI technique consisted of
three isocentres and three overlapping arcs: the head and neck, the chest, and the pelvis. The plans were prescribed to ensure, at a
minimum, 95% planning target volume dose coverage with the prescription dose (percentage of volume receiving dose of 12 Gy
was 95%) and maximum dose of 109.8%. Mean dose to lung was restricted at 8.6 Gy. Results: The total body volume in the study
was 15469 cm3 and the PTV volume was 11322 cm3. The mean dose to PTV was 104%. The homogeneity index was 0.09. Sparing
of normal tissues with adequate coverage of skeletal bones was shown to be feasible with Rapid Arc. The study demonstrates that
VMAT is feasible for TBI treatment. Unlike conventional TBI chest wall boost with electrons was not required. Conclusion: The
technique for total body irradiation using RapidArc VMAT was found feasible and is undergoing further studies prior to clinical
use.
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Introduction
Total body irradiation (TBI) with mega-voltage photon beams
has been accepted as an important component of manag-
ement for a number of hematologic malignancies, generally as
part of bone marrow conditioning regimens. The goal of the
treatment is to ensure that the prescription dose is delivered
with dose homogeneity of ±10% at the patient mid-line.1
Given the large volume of radiation involved it is not
surprising that several techniques have been developed to
deliver TBI. The most commonly recommended technique
utilizes parallel opposed antero-posterior (AP-PA) beams to
ensure a homogenous and uniform dose. This beam
arrangement usually requires the patient to be treated in a
standing or sitting position at extended SSD.2 This is usually
coupled with partial transmission blocks to shield the lungs.
This is usually followed by an electron boost to shielded areas
to ensure adequate doses. In order to get acceptable dose
variation across the mid line 10 MV or higher photon
energies are required (± 30% if skin dose is included).
However the disadvantage with this technique is that it
requires a sick patient to stand for prolonged periods of time
often in excess of 40 minutes.3 In addition the reproducibility
of treatment position is less and positioning of the shields is
cumbersome. Hence several new techniques have been
designed, some even incorporating innovative machines to
deliver TBI in a more simple way. Some of these techniques
include treatment using lateral opposing fields,2 step
translation and dynamic field matching 4 and recently helical
tomotherapy.5 While these techniques are innovative they
are also limited in their applicability to the institute or
innovator of origin. Further in institutes with limited
machine availability as in India these techniques are difficult
to apply. Time on the machine is a precious resource and
treatment time in excess of 40 minutes for a single patient is
difficult to justify especially in our setting.
In recent years, TBI has been planned using Helical
Tomotherapy. Dosimetrically the dose distribution is more
homogeneous as compared to standard extended SSD AP-PA
treatment.6 It has the advantage that the patient can be
treated in supine position without requiring compensators,
specialized lung shields and beam spoilers. However, the
treatment time of more than one hour with this technique
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may limit its clinical application. Volumetric modulated arc
therapy (VMAT) is able to increase the treatment delivery
efficiency while increasing the target conformality and
reducing the radiation dose to organs at risk (OARs). During a
VMAT treatment, the gantry rotates around the patient while
the beam is modulated continuously. Both the dose rate and
gantry speed can be modulated to achieve optimal dose
distribution. Studies showed that VMAT could achieve
satisfactory dose conformity and normal organ sparing for a
variety of treatment sites.7
Use of VMAT to deliver total marrow irradiation (TMI) has
also been reported by several authors.8, 9 Surucu et al. have
shown that that median dose difference between TLD
measured and TPS measured dose was 0.5%.10 Han et al.
compared VMAT and Helical Tomotherapy and showed that
use of VMAT TMI could achieve comparable target volume
coverage, organ at risk doses with reduced beam on time.11
However given the difference in the difference of target
volume between TMI and TBI applicability of VMAT for
delivering TBI remains to be investigated.12
The purpose of this study is to develop a total body irradiation
technique that does not require additional devices or
sophisticated processes. The technique aims to deliver a
uniform dose to the entire body while keeping the lung dose
within the tolerance level using VMAT.
Methods and Materials
Pre-existing computed tomography (CT) data-set of an adult
patient, treated previously with craniospinal radiation,
imaged from the vertex of the skull up to the mid-thigh was
used for the planning purpose. The planning target volumes
included entire body trimmed to 3 mm below the skin. The
organs at risk included the lungs and kidneys.
Treatment planning was performed on the Eclipse 10.0
platform (Varian Medical Systems, Palo Alto, California,
USA). A dose of 12 Gy in 10 fractions was prescribed to the
target volume. Dose was normalized so that 95% of the
prescribed dose covered 95% of the PTV. Planning objectives
for PTV aimed to limit the minimum and maximum doses. 6
MV photon beam was used for the arc fields. A 120-leaf
multi-leaf collimator (MLC) was used for beam modulation.
There were 60 leaves on each side of the MLC, with each of
the central 40 leaves projecting a 5 mm width at 100 cm
source-to-surface distance (SSD), and each of the peripheral
20 leaves projecting a 10 mm width at 100 cm SSD.
The maximum dose rate used was 200 monitor units (MU) per
minute. The maximum gantry rotation speed was 4.8
degree/s. Due to physical limits to the maximum MLC leaf
extensions as well as the maximum jaw size; multiple fields
were needed to deliver treatment to the complete target
volumes. Six arc fields, arranged along the patient’s
longitudinal axis, were used. The range of gantry rotation
angles was from 0-179 for all the arc fields. For efficient
treatment delivery, each arc field always had the opposite
gantry rotation direction in relation to adjacent fields, so that
after each arc field rotation, the gantry will be at the starting
position of the next field. The six arcs had a total number of 3
isocentres using asymmetric jaw settings to cover the entire
PTV length. Field width was set to 40 cm, while field length
was 15cm.
For each arc field in the VMAT plans, 177 control points were
defined, each corresponding to an arc segment of about 2
degree. Progressive resolution algorithm was used for arc
field optimization, and the anisotropic analytical algorithm
(AAA) was used for final dose calculation, with a calculation
grid size of 0.25 cm. Plan was evaluated as per the
institutional recommendations.
The median dose (D50) and the dose covering 2% of the
volume (D2) were evaluated for normal organs and target
volumes. The percentage target volume that received at least
12 Gy (V12) was used for the evaluation of target dose
coverage. Plan is quantitatively evaluated from
dose-volume-histogram (DVH) analysis, assessing for PTV:
mean dose, percentage of volume receiving 110% of the
prescribed dose and target homogeneity index (HI) defined as
D2%-D98%: for OARs, the analysis included the median dose
(D50%) and D2%.
Plan quality assurance was performed using an Octavius II
phantom with a PTW 729 ionization chamber
(Physikalish-TechnischeWerkstätten-Freiburg, Freiburg,
Germany) array. The verification plan consisted of all 3 plans
delivered to a single isocenter. Gamma evaluation was done
using Low’s method with a dose difference of 3% and distance
to agreement of 3 mm.13 Results were analyzed on the
VeriSoft software version 4.2 (Physikalish- TechnischeW-
erkstätten-Freiburg, Freiburg, Germany).
Results
The total PTV volume was 11322 cc while the volume of lung
and kidneys were 664 cc and 144.1 cc, respectively. For this
initial planning study no further organs at risk were defined.
The total length of the target volume was 63 cm. An
optimization PTV was created by trimming the PTV by 3 mm
below the skin surface in order to ensure better plan
optimization as per our previous clinical experience in other
sites. Further in order to ensure adequate sparing of the
kidney and lung dummy structures were created by
expanding the contours of these organs by 3 mm. The
optimization PTV was trimmed from the lung, kidney and
this dummy structure. Couch structures were used in
addition to ensure that beam attenuation through the couch
was accounted for.
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Table 1 lists the optimization objectives used for the planning
purpose. Normal tissue optimization (NTO) parameter was
not used. Optimization was continued for four levels till
desired optimum solution was obtained. The total time taken
for the initial field placement and optimization was 40
minutes. After the initial optimization the plans were
calculated and normalized to ensure minimum target
coverage as per the criteria mentioned above.
TABLE 1: Planning objectives used in VMAT TBI.
Type Volume Limit Vol[%] Dose(cGy) Priority
Point Kidney Upper 0 1200 30
Point Kidney Lower 100 900 50
Mean Kidney NA NA 1000 40
Point Lung Upper 0 1200 30
Point Lung Lower 100 800 50
Mean Lung NA NA 850 50
Point PTV Body Upper 0 1220 65
Point PTV Body Lower 100 1200 65
NA = Not applicable
Portions of the optimization PTV receiving more than 107%
and less than 95% was delineated. Subsequently further
optimization was performed using the original plan as the
base plan. Higher priorities were assigned to these newly
created dummy structures to eliminate overdose and increase
dose to volumes receiving overdose. This process was
repeated 4 times till an optimum plan was generated which
met our predefined acceptability criteria. The dosimetric
results obtained in this plan for the target volumes and
various organs at risk are presented in Table 2 and 3,
respectively.
TABLE 2: Target volume dose. PTV D98 and D2 are minimum dose to
98% and 2% volumes, respectively. PTV D50 is the median dose.
PTV D98 1132.68 cGy
PTV D2 1251.48 cGy
PTVD50 1202 cGy
PTV Mean dose 1200 cGy
PTV 3D Dose Maximum 1317.8 cGy
PTV 3D Dose Minimum 903.1 cGy
TABLE 3: Organ at risk doses. The D98, D67, D33 and D2 are minimum
dose to 98%, 67%, 33% and 2% volumes, respectively. V8 is the
percentage volume receiving 8 Gy.
OAR Dmean D98 D2 D67 D33 V8
Lung 864.9 761.27 1111 798.5 690.462 65%
Kidney 985.7 869.48 1141 945 1021 NA
Color wash dose displays (Figure 1, 2 and 3) show relative
sparing of the organs at risk with homogeneous coverage of
the rest of the body. Dose volume histograms are presented in
Figure 4.
The total time taken for optimization and calculation of the
plans was 5 hours. Plan quality assurance revealed that
percentage of pass pixels was 93% using the Lows criteria at ±
3% dose difference and a distance to agreement of 3 mm for
the composite plan.
FIG. 1: RapidArc volumetric arc therapy TBI isodose distributions in color wash - Thoracic axial. Isodose lines shown correspond to: 7.2 Gy
(60%).
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FIG. 2: RapidArc volumetric arc therapy TBI isodose distributions in color wash - Abdominal axial. Isodose lines shown correspond to: 8.4 Gy
[70% of prescribed dose].
FIG. 3: Coronal section of body showing the isodose distribution in color wash. Isodose lines shown correspond to 11.4 Gy [95% of the prescribed
dose].
Volume 3 • Number 2 • 2015 International Journal of Cancer Therapy and Oncology 5
www.ijcto.org
© Chakraborty et al. ISSN 2330-4049
FIG. 4: Cumulative dose volume histogram. Planning target volume [PTV] in cyan color, kidney in yellow color and lung in green color.
Discussion
TBI is a valuable addition to hematopoietic stem cell
transplantation programmes as it allows delivery of a uniform
dose to entire body including all sanctuary sites regardless of
blood supply. In addition chance of cross resistance with
other systemic chemotherapeutic agents is less and there is no
problem with altered dose intensity due to elimination
through the excretory system. As per the ACR-ASTRO
practice guidelines use of doses in the range of 12 - 15 Gy in 8
- 12 fractions over 4 days is ideal.14 In addition to a low dose
per fraction and multiple treatments a low dose rate below 0.2
Gy / min is associated with reduced risk of late side effects.
Low dose TBI typically utilizes doses in the range of 2 - 8 Gy
in 1- 4 fractions.
Unfortunately in a resource poor nation like India it is not
possible to devote an entire machine for TBI given the low
case load. Moreover implementation of TBI requires
extensive quality assurance especially as several accessories
and atypical patient positioning are involved. In addition to
above time taken for each treatment extends well beyond 40
minutes for each session depending on the machine used for
treatment. Hence most of the Indian institutes are reluctant
to start TBI programs.
Recently attention has been focused on use of Rotational
IMRT techniques like Helical Tomotherapy for TBI
delivery.5,15 Delivering TBI using Helical Tomotherapy,
however, requires the availability of the said machine which
is one limiting factor in its widespread use. Another concern
is that the nature of radiation delivery in Helical
Tomotherapy exposes only a small volume of the target to the
radiation dose instantaneously.16 This is unlike conventional
TBI where the entire blood pool and bone marrow gets
irradiated simultaneously. Our present technique of
treatment delivery using three isocentric arcs can minimize
this issue as a larger volume of blood pool gets exposed to the
radiation. Further the time taken to deliver each arc is of the
order of 1 - 2 minutes which ensures that the entire blood
pool gets exposed at each gantry rotation. Use of
chemotherapy preconditioning regimens can further reduce
the risk of missing circulating clonogenic cells.
Due to the unavailability of an anthropomorphic phantom we
have used the Octavius Phantom for treatment verification.
However, Aydogan et al. have used a similar Mapcheck
phantom for absolute and relative dose verification of the
treatment plan when delivering RapidArc for Total Marrow
Irradiation.8 Chandraraj et al. have also shown that the PTW
array along with a Octavius phantom yields equivalent
dosimetric results on quality assurance of RapidArc IMRT as
compared to EDR2 films.17However we do plan to delivery
and verify the plan using thermoluminescence dosimetry on
an anthropomorphic phantom once it has been purchased.
A potential problem with TBI delivered using rotational
techniques is that the instantaneous dose rate may not be less
than 0.2 Gy per minute as recommended.14 In our present
technique the average time taken to deliver two arcs at each
isocenter was 2.48 minutes. Also the total dose delivered per
fraction is 1.2 Gy per fraction and the total beam on time is
7.2 minutes the total dose rate comes to be 0.17 Gy/min. This
compares favorably to the previously described Helical
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Tomotherapy technique where the instantaneous dose rates
at each treated sub-volume are necessarily higher due to the
nature of treatment delivery. A bigger advantage for resource
constrained setting like ours is that this magnitude of total
beam on time allows us to treat the patient on a standard
treatment slot on the same machine with image guidance. In
addition time and effort required for quality assurance is also
less as the entire quality assurance can be performed within
20 minutes for a typical case and can be clubbed together
with additional QA being performed on the given day.
The present planning strategy incorporated the creation of an
optimization PTV which was trimmed 3 mm below the
surface. It is to be noted that the average thickness of the skin
is around 2 - 3 mm. The present planning strategy has been
extrapolated from areas requiring optimization for superficial
tumors especially in the head neck region. In the present
study, the TPS reported doses at the surface were 75 - 80%. It
is also known that the AAA algorithm can underestimate
doses at 2 mm depth as compared to direct measurements by a
mean of 4.71% (9.17%).18 We plan to conduct further studies
of direct verification of superficial doses after acquisition of
the anthropomorphic phantom using thermo-luminescence
dosimetry for plans generated in multiple CT data-sets in the
near future.
Use of RapidArc for delivering TBI was described in abstract
form in a recent paper.19 However in this paper the patient
was laid down in the floor and extended SSD partial 80 degree
arcs were used. In contrast in our technique patient can rest
in a supine position comfortably on the treatment couch itself
and treatments can be conducted without requiring extended
SSDs. Another advantage of the presently described
technique is that it lends itself to image guidance very well
with position verification using CBCT / kV imaging possible
using on board imaging systems. Further additional beam data
for extended SSD does not need to be generated saving
precious physics time. Additional electron boosts for chest
wall due to under-dosage arising from use of lung blocks as
seen in conventional TBI treatments is also not required.
Conclusion
The study demonstrates that VMAT planning technique
described here is feasible for TBI treatment. Unlike conven-
tional TBI chest wall boost with electrons is not required and
treatment can be done on the treatment couch without re-
quiring extended SSD techniques. Further implementation
and quality assurance of the process is simplified as com-
pared to standing TBI with extended SSD. As patients can be
treated in a supine position hence comfort and tolerability is
likely to be significantly better also. The shorter time re-
quired would be beneficial to departments with limited ma-
chine resources.
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